Stay updated on GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial

Sign up to get notified when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-04-30T13:46:26.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.
    Difference
    1.0%
    Check dated 2025-04-16T01:41:04.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 19, 2025.
    Difference
    1.0%
    Check dated 2025-04-08T20:11:06.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The page has added a Phase 2 Study of Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults with FLT3-ITD Relapse/Refractory AML (AGORA-1) with a date of 2025-02-19, while the previous entry for the same study dated 2023-11-13 has been removed.
    Difference
    7%
    Check dated 2025-02-24T16:04:37.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    6%
    Check dated 2025-02-10T08:57:46.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T04:51:19.000Z thumbnail image

Stay in the know with updates to GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.